X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BMC MEDICAL IMAGING

期刊標題檢索 BMC MED IMAGING 最新評論: I initially invited 7 reviewers, but now it has turned into a technica... (2024-02-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BMC MEDICAL IMAGING]您好,您是該頁面的第 44578 位訪客。

期刊簡介
期刊名稱BMC MEDICAL IMAGING BMC MEDICAL IMAGING
LetPub Score
5.2
50 ratings
Rate

Reputation
5.9

Influence
3.8

Speed
8.8

期刊簡稱BMC MED IMAGING
ISSN1471-2342
h-index31
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.600.7011.157
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q2114 / 333

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
BMC Medical Imaging is an open access journal publishing original peer-reviewed research articles in the development, evaluation, and use of imaging techniques and image processing tools to diagnose and manage disease.
官方網站https://www.springer.com/journal/12880
在線稿件提交https://www.editorialmanager.com/BMIM
開放訪問Yes
出版商BioMed Central
主題領域RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
出版國/地區ENGLAND
發行頻率
創刊年2001
每年文章數213每年文章數趨勢
黃金OA百分比99.84%
OA Related Info
APC: Yes( GBP2190; USD2990; EUR2490; )
APC waiver:Check Notes
Other charges: No
Keywords: medical imaging、image processing、imaging techniques
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardOpen peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGSCIEQ260/204
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2342%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 27 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【BMC MEDICAL IMAGING】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640831
    BIOMATERIALS570916
    BIOMEDICINE & PHARMACOTHERAPY498343
    Frontiers in Pharmacology486859
    JOURNAL OF ETHNOPHARMACOLOGY478112
    Journal of Materials Chemistry B476060
    Frontiers in Immunology457932
    COLLOIDS AND SURFACES B-BIOINTERFACES419227
    COMPUTERS IN BIOLOGY AND MEDICINE416404
    Frontiers in Oncology413445
  •  

    BMC MEDICAL IMAGING BMC MEDICAL IMAGING
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [BMC MEDICAL IMAGING] 的評論撰寫評論
作者: 乌龙笑萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 17:18:34 評論於
I initially invited 7 reviewers, but now it has turned into a technical review. What does this mean?
(0) 讚! | 乌龙笑萱

作者: 碧波海云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-04 20:27:15 評論於
Did you win, bro?
(0) 讚! | 碧波海云

作者: 碧波海云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 19:55:34 評論於
Nothing
(0) 讚! | 碧波海云

作者: 暗月寺采萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-02 16:51:12 評論於
I want to ask, I sent an email about a technical issue, but when I click on the webpage, I don't know where to make modifications. What should I do?
(0) 讚! | 暗月寺采萱

作者: Anna Isabel


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-19 14:00:54 評論於
Review speed: 3.0 Experience sharing: There has only been one reviewer for the second review, rejection after more than two months, only one out of four reviewers rejected, the others all agreed
(0) 讚! | Anna Isabel

作者: Rock North


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-10 20:55:40 評論於
Are we allowed to recommend reviewers when submitting a manuscript?
(0) 讚! | Rock North

作者: 雅晗三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-09 12:24:10 評論於
Review speed: 6.0 | Submission hit rate: 50.0
Emphasis on research direction: Imaging; Emphasis on sharing clinical experience: Submitted on January 12, revised on March 23, under peer review on April 24, major revision on April 30, revised on May 10, minor revision on May 11. The revision process has been quite lengthy, currently still under technical review. Hopefully the outcome will be positive
(0) 讚! | 雅晗三岁啦

作者: 仲夏雨旋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-09 22:47:00 評論於
I am almost four months now and still no news
(0) 讚! | 仲夏雨旋

作者: 红爱小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-11 14:42:37 評論於
Review speed: 6.0 | Submission hit rate: 5.0 Focus on research direction: Image experience sharing: It has been almost three months and there is still no news
(0) 讚! | 红爱小娘子

作者: 红爱小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-15 08:36:00 評論於
Any news?
(0) 讚! | 红爱小娘子

作者: Xanthe McDonald


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-28 14:44:35 評論於
How long have you been investing?
(0) 讚! | Xanthe McDonald

作者: 流影冷梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-19 13:18:44 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0
Experience sharing: It's a long way off
(0) 讚! | 流影冷梅

作者: 流影冷梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-19 12:00:45 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Experience sharing: Using the Springer Nature platform, initially 4 reviewers, then 8, now 10, and still no review feedback received
(0) 讚! | 流影冷梅

作者: 西行寺含蓉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-06 10:12:35 評論於
Review speed: 2.0 | Submission acceptance rate: 75.0
Sharing experience: Submission in January will be published in May
(0) 讚! | 西行寺含蓉

作者: 觅雁小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-03 08:35:41 評論於
Please translate the following paragraph into English and Japanese, and title them as ":" and ":"
(0) 讚! | 觅雁小娘子

作者: 北陆萧曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-09 21:37:51 評論於
Are you still accepting case reports now?
(0) 讚! | 北陆萧曼

作者: 韩仙俊


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-03-04 19:46:15 評論於
Submitted at the end of August in the 21st year, the reviewing process came back at the end of December. It required major revisions once and was reviewed by 3-5 individuals. After the revisions were made, it was accepted at the end of February in the 22nd year. It might have been delayed due to the impact of the pandemic; the reviewing process was slow.
(0) 讚! | 韩仙俊

作者: Orville Lincoln


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-04 14:42:10 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 75.0
Emphasis in Research Area: Clinical Cardiovascular Direction
Experience Sharing: The speed is relatively slow, submitted in August 2021, accepted by the end of February 2022, accepted after a major revision two months later, with 3-5 reviewers in the first review
(0) 讚! | Orville Lincoln

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:47:52 評論於
Currently ORCID is optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researchers associated with their publications to use an ORCID iD. 
19. How to add ORCID ID if it is not provided when an article is published?
ORCID stands for Open Researcher and Contributor ID. ORCID iD is a unique and persistent scholarly identity for authors, distinguishing them from other researchers and recording all of their relevant research activities. To add an ORCID iD after publication, you need to log into each author's account and link it in the account information settings
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:59:22 評論於
Manuscript of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 22:34:17 評論於
Is it necessary to provide the ORCID ID of each author when submitting a manuscript?
(0) 讚! | 龙鳞孝礼

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:23:26 評論於
What is MS?
(0) 讚! | 魂魄彦露

作者: 重阳柔煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-19 08:17:45 評論於
Is it so fast? I saw on the magazine's official website that the review comments are given in 39 days
(0) 讚! | 重阳柔煦

作者: 天神院曼文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-21 20:24:51 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 75.0 | Page Charges: 2290.0
Research Focus: Image Experience Sharing: Feedback returned in about 20 days
(0) 讚! | 天神院曼文

作者: Anning-


領域: 医学
審稿時間: 7.0 month(s)
結果: 修改後接受


撰寫評論

2021-03-07 23:04:48 評論於
Hello, may I ask which bank you use to pay the layout fee? Isn't the magazine based in the UK? The magazine notified me to make the payment to BioMed Central Ltd Bankers: Deutsche Bank AG Bank, but I noticed that this bank is in Germany. I'm not sure if yours is the same as mine.
(2) 讚! | Anning-

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [BMC MEDICAL IMAGING] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*